Oral azacitidine improves overall survival in patients with AML in remission Presented ByDr Andrew Wei, Alfred Hospital, Australia TrialPhase 3, QUAZAR AML-001 ConferenceASH 2019 TypePeer-reviewed article 5 March 2020 21:39